B-EPIC
IGNYT × ORYGN
One drop, three metabolic pathways. A science-backed approach to appetite, energy, and gut health — built into a business you can actually share.
B-Cardio pairs a nitric oxide booster with a raspberry-flavored cardio health formula — a simple daily addition built to support the heart that carries everything else you do.
triGLP was built around a simple idea: real metabolic health isn't one hormone, it's three working together. Each drop activates all three.
Stimulates your body's natural GLP-1 hormone release — supporting appetite control, glucose regulation, and metabolic signalling at the source.
Supports gut integrity and nutrient absorption through the GLP-2 pathway — the often-overlooked third pillar of complete metabolic health.
The third receptor pathway triGLP is formulated to engage, working alongside GLP-1 and GLP-2 for a fuller metabolic response.
“Building a business is easier when the product does the work.”
triGLP is designed for consistency, not complexity — supporting real-world results that customers can feel and trust. That translates into confidence when sharing, strong retention, and natural repeat demand.
Check your email for a welcome message and more details about triGLP.
Know Before You Choose
A closer look at the leading weight-loss shots — and where triGLP fits.
The most talked-about weight loss shots are Wegovy (semaglutide) and Zepbound (tirzepatide). People also frequently refer to Ozempic and Mounjaro; however, these are technically FDA-approved for Type 2 diabetes, though doctors often prescribe them “off-label” for weight management.[1][2][3]
These weekly injections belong to a class of medications called GLP-1 receptor agonists. They work by mimicking a gut hormone that slows digestion, signals to your brain that you are full, and significantly reduces your appetite.[1][2]
To help narrow down which approach is right for you, start with:
Gastrointestinal issues are the most common side effects of GLP-1 weight loss shots like Wegovy and Zepbound. Because these medications work by slowing down how fast your stomach empties, about half of the people who take them experience mild to moderate digestive discomfort, which usually improves over time.[1][2]
Most common symptoms peak when you first start the medication or when your doctor increases your dose:
Yes, deaths have been reported to global drug monitoring agencies among people taking GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound. However, health regulators emphasize that a reported death does not automatically mean the drug caused it, as many patients taking them already have high-risk underlying conditions like severe obesity, heart disease, or diabetes.[1][2][3]
The primary scenario surrounding reported fatalities and investigations: severe medical complications, where fatalities are linked directly to the known risks of the medication, usually stemming from rare and severe complications.
